Increased feeding in fatty Zucker rats by the thiazolidinedione BRL 49653 (rosiglitazone) and the possible involvement of leptin and hypothalamic neuropeptide Y

British Journal of Pharmacology

Volumn 122, Issue 7, 1997, Pages 1405-1410

  Wang, Qiong ^a   Dryden, Simon ^a   Frankish, Helen M ^a   Bing, Chen ^a   Pickavance, Lucy ^a   Hopkins, David ^a   Buckingham, Robin ^b   Williams, Gareth ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

BRL 49653; Insulin; Leptin; NPY; Rosiglitazone; Thiazolidinedione

Indexed keywords

ANTIDIABETIC AGENT; CORTICOSTERONE; INSULIN; LEPTIN; MESSENGER RNA; NEUROPEPTIDE Y; ROSIGLITAZONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; FEEDING; FOOD INTAKE; HYPERPHAGIA; HYPOTHALAMUS; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MALE; NONHUMAN; OBESITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; WEIGHT GAIN;

EID: 0030833895     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701535     Document Type: Article

References (38)

1. BANKS, W.A., KASTIN, A.J., HUANG, W., JASPAN, J.B. & MANESS, L.M. (1996). Leptin enters the brain by a saturable system independent of insulin. Peptides, 17, 305-311.
2. BILLINGTON, C.J., BRIGGS, J.E., GRACE, M. & LEVINE, A.S. (1991). Effects of intracerebroventricular injection of neuropeptide Y on energy metabolism. Am. J. Physiol., 260, R321-327.
3. BRAISSANT, O., FONFELLE, F., SCOTTO, C., DANGA, M. & WALLI, W. (1996). Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-α and -β and -γ in the adult rat. Endocrinology, 137, 354-366.
4. CAMPFIELD, L.A., SMITH, F.J., GUISEZ, Y., DEVOS, R. & BURN, P. (1995). Recombinant mouse OB protein: evidence for a signal linking adiposity and central neuronal networks. Science, 269, 546-549.
5. CARO, J.F., SINHA, M.K., KOLACZYNSKI, J.W., ZHANG, P.L. & CONSIDINE, R.V. (1996). Leptin: the tale of an obesity gene. Diabetes, 45, 1455-1462.
6. CHRONWALL, B.M., DIMAGGIO, D.A., MASSARI, V.J., PICKEL, V.M., RUGGIERO, D.A. & O'DONOHUE, T.L. (1985). The anatomy of neuropeptide Y containing neurones in the rat brain. Neuroscience, 15, 1159-1181.
7. CORRIN, S.E., MCARTHY, H.D., MCKIBBIN, P.E. & WILLIAMS, G. (1991). Unchanged hypothalamic neuropeptide Y concentrations in hyperphagic, hypoglycemic rats: evidence for specific metabolic regulation of hypothalamic neuropeptide Y. Peptides, 12, 425-430.
8. CUSIN, I., ROHNER-JEANRENAUD, F., STRICKER-KRONGRAD, A. & JEANRENAUD, B. (1996). The weight reducing effect of an intracerebroventricular bolus injection of leptin in genetically obese fa/fa rat. Diabetes, 45, 1446-1450.
9. DE VOS, P., LEFEBVRE, A.-M., MILLER, S.G., GUERRE-MILLO, M., WONG, K., SALADIN, R., HARMANN, L.G., STAELS, B., BRIGGS, M.R. & AUWERX, J. (1996). Thiazolidinediones repress ob gene expression in rodents via activation of peroxisome proliferator-activated receptor γ. J. Clin. Invest., 98, 1004-1009.
10. DRYDEN, S., FRANKISH, H.M., WANG, Q. & WILLIAMS, G. (1994). Neuropeptide Y and energy balance: one way ahead for the treatment of obesity. Eur. J. Clin. Invest., 24, 293-308.
11. ELDERSHAW, T.P.D., RATTIGAN, S., CAWTHORNE, M.A., BUCKINGHAM, R.E., COLQUHOUN, E.Q. & CLARK, M.G. (1995). Treatment with the thiazolidinedione BRL 49653 decreases insulin resistance in obese Zucker hindlimb. Horm. Metab. Res., 27, 169-172.
12. ERICKSON, J.C., CLEGG, K.E. & PALMITER, R.D. (1996a). Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature, 381, 415-418.
13. ERICKSON, J.C., HOLLOPETER, G. & PALMITER, R.D. (1996b). Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y. Science, 274, 1704-1707.
14. FUJIWARA, T., YOSHIOKA, S., YOSHIOKA, T., USHIYOMA, I. & HORIKOSHI, H. (1988). Characterization of new oral antidiabetic agent CS-045: studies in KK and ob/ob mice and Zucker fatty rats. Diabetes, 37, 1549-1558.
15. HISANO, S., KAGOTANI, Y., TSURUO, Y., DAIKOKU, S., CHIHARA, K. & WHITNALL, M.H. (1988). Localisation of glucocorticoid receptors in neuropeptide Y-containing neurones in the arcuate nucleus of the rat hypothalamus. Neurosci. Lett., 95, 13-18.
16. IKEDA, H., WEST, D.B. & PUSTEK, J.J. (1986). Intraventricular insulin reduces food intake and body weight of lean but not obese Zucker rats. Appetite, 1, 381-386.
17. MAFFEI, M., HALAAS, J.L., RAVUSSIN, E., PRATLEY, R.W., LEE, G.H., ZHANG, Y., FEI, H., KIM, S., LALLONE, R., RANGANATHAN, S., KERN, N. & FRIEDMAN, J.M. (1995). Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight reduced subjects. Nature Med., 1, 1155-1161.
18. MCKIBBEN, P.E., COTTON, S.J., MCMILLAN, S., HOLLOWAY, B., MAYERS, R., MCCARTHY, H.D. & WILLIAMS, G. (1991). Altered neuropeptide Y concentrations in specific hypothalamic regions of obese Zucker rats: possible relationship to obesity and neuroendocrine disturbances. Diabetes, 40, 1423-1429
19. MERCER, J.G., HOGGARD, N., WILLIAMS, L.M., LAWRENCE, C.B., HANNAH, L.T., MORGAN, P.J. & TRAYHURN, P. (1996). Coexpression of leptin receptor and preproneuropeptide Y mRNA in arcuate nucleus of mouse hypothalamus. J. Neuroendocrinol., 8, 530-532.
20. MORRIS, B.J. (1989). Neuronal localisation of neuropeptide Y gene expression in rat brain. J. Comp. Neurol., 290, 358-368.
21. NOLAN, J.J., LUDRICK, B.L., BEERDSEN, P., JOYCE, M. & OLEFSKY, J.M. (1994). Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone. N. Engl. J. Med., 331, 1188-1193.
22. NOLAN, J.J., OLEFSKY, J.M., NYCE, M.R., CONSIDINE, R.V. & CARO, J.F. (1996). Effect of troglitazone on leptin production. Diabetes, 45, 1276-1278.
23. OAKES, N.D., KENNEDY, C.J., JENKINS, A.B., LAYBUTT, D.R., CHISHOLM, D.J. & KRAEGEN, E.W. (1994). A new antidiabetic agent, BRL 49653, reduces lipid availability and improves insulin action and glucoregulation in the rat. Diabetes, 43, 1203-1210.
24. PELLEYMOUNTER, M.A., CULLEN, M.J., BAKER, M.B., HECHT, R., WINTERS, D., BOONE, T. & COLLINS, F. (1995). Effects of the obese gene product on body weight regulation in ob/ob mice. Science, 269, 540-543.
25. SALTIEL, A.R. & OLEFSKY, J.M. (1996). Thiazolidinediones in the treatment of insulin-resistance and Type II Diabetes. Diabetes, 45, 1661-1669.
26. SCHWARTZ, M.W., FIGLEWICZ, D.P., BASKIN, D.G., WOODS, S.C. & PORTE, D. (1992). Insulin in the brain: A hormonal regulator of energy balance. Endocrine Rev., 13, 387-414.
27. SCHWARTZ, M.W., SEELEY, R.J., CAMPFIELD, L.A., BURN, P. & BASKIN, D.G. (1996). Identification of targets of leptin action in rat hypothalamus. J. Clin. Invest., 98, 1101-1106.
28. SMITH, S.A., CAWTHORNE, M.A., COYLE, P.J., HOLDER, J.C., KIRKHAM, D., LISTER, C.A., MURPHY, G.J. & YOUNG, P.W. (1993). BRL 49653 normalises glycaemic control in Zucker fa/fa rats by improving hepatic and peripheral tissue sensitivity to insulin. Diabetologia, 36, Suppl 1, A184.
29. STANLEY, B.G., KYRKOULI, S.E., LAMPERT, S. & LEIBOWITZ, S.F. (1986). Neuropeptide Y chronically injected into the hypothalamus: a powerful neurochemical inducer of hyperphagia and obesity. Peptides, 7, 1189-1192.
30. STEPHENS, T.W., BASINSKI, M., BRISTOW, P.K., BUE-VALLESKEY, J.M., BURGETT, S.G., CRAFT, L., HALES, J., HOFFMANN, J., HSIUNG, H.M., KRIAUCIUNAS, A., MACKELLAR, W., ROSTECK, P.R., SCHONER, B., SMITH, D., TINSLEY, F.C., ZHANG, X.Y. & HEIMAN, M. (1995). The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature, 377, 530-532.
31. STRACK, A.M., SEBASTIAN, R.J., SCHWARTZ, M.W. & DALLMAN, M.F. (1995). Glucocorticoids and insulin: reciprocal signals for energy balance. Am. J. Physiol., 268, R142-149.
32. TAKAYA, K., OGAWA, Y., ISSE, N., OKAZAKI, T., SATOH, N., MASUZAKI, H., MORI, K., TAMURA, N., HOSODA, K. & NAKAO, J. (1996). Molecular cloning of rat leptin receptor isoform complementary DNAs - identification of a missense mutation in Zucker fatty (fa/fa) rats. Biochem. Biophys. Res. Commun., 225, 75-83.
33. TEMPEL, D.L. & LEIBOWITZ, S.F. (1993). Glucocorticoid receptors in PVN: interactions with NE, NPY, and Gal in relation to feeding. Am. J. Physiol., 265, E794-800.
34. WANG, Q., BING, C., AL-BARAZANJI, K., MOSSAKOWASKA, D.E., WANG, X-M., MCBAY, D.L., NEVILLE, W.A., TADDAYON, M., PICKAVANCE, L., DRYDEN, S., THOMAS, M.E.A., MCHALE, M.T., GLOYER, L.S., WILSON, S., BUCKINGHAM, R., ARCH, J.R.S., TRAYHURN, P. & WILLIAMS, G. (1997). Interactions between leptin and hypothalamic neuropeptide Y neurones in the control of food intake and energy homeostasis in the rat Diabetes, 46, 335-341.
35. WILLIAMS, G., GILL, J.S., LEE, Y.C., CARDOSO, H.M., OKPERE, B.E. & BLOOM, S.R. (1989). Increased neuropeptide Y concentrations in specific hypothalamic regions of streptozocin-induced diabetic rats. Diabetes, 38, 321-327.
36. ZARJEVSKI, N., CUSIN, I., VETTOR, R., ROHNER-JEANRENAUD, F. & JEANRENAUD, B. (1993). Chronic intracerebroventricular neuropeptide-Y administration to normal rats mimics hormonal and metabolic changes of obesity. Endocrinology, 133, 1753-1758.
37. ZHANG, B., GRAZIANO, M.P., DOEBBER, T.W., LEIBOWITZ, M.D., WHITE-CARRINGTON, S. & SZALKOWSKI, D.M. (1996). Down-regulation of the expression of the obese gene by an antidiabetic thiazolidinedione in Zucker diabetic fatty rats and db/db mice. J. Biol. Chem., 271, 9455-9459.
38. ZHANG, Y., PROENCA, R., MAFFEI, M., BARONE, M., LEOPOLD, L. & FRIEDMAN, J.M. (1994). Positional cloning of the mouse obese gene and its human homologue. Nature, 372, 425-432.